Skip to main content

Table 5 Determinants of changes in Zearalenone and Deoxynivalenol levels in breast milk during lactational period*

From: Longitudinal follow-up of zearalenone and deoxynivalenol mycotoxins in breast milk in the first five months of life

 

Zearalenone, ng/mL

Deoxynivalenol, ng/mL

Mean

[95% Wald CI]

Wald

Chi-Square

P*

Mean

[95% Wald CI]

Wald

Chi-Square

P*

Intercept

 

126.69

< 0.001

 

56.19

< 0.001

Sampling time

 

24.91

< 0.001

 

10.88

0.004

 Visit 1

0.67 [0.58–0.76]a

  

15.8 [10.7–20.8]ab

  

 Visit 2

0.51 [0.38–0.63]b

  

20.1 (14.2–25.9]a

  

 Visit 3

0.40 [0.28–0.52]c

  

11.1 [6.6–15.6]b

  

Sex

 

3.72

0.054

 

0.22

0.641

 Male

0.44 [0.39–0.49]

  

16.6 [13.5–19.8]

  

 Female

0.61 [0.44-0.708]

  

14.6 [6.9–22.4]

  

Birth order

 

0.04

0.842

 

1.24

0.265

 First child

0.53 [0.38–0.68]

  

13.9 [8.3–19:6]

  

 ≥ second

0.52 [0.46–0.58]

  

17.4 [12.8–21.9]

  

Weight for age, z score

 

5.86

0.015

 

1.09

0.297

  1. *Generalized Estimating Equations involving sampling time, sex, birth order, WAZ.
  2. a,b,c Groups with different letters are statistically different from each other; p < 0.05
  3. CI: Confidence Interval